Scholarlink

Background <p>Achieving target vancomycin exposures is crucial for treating pediatric sepsis but is complicated by altered pharmacokinetics in critically ill children. This study investigated whether a loading dose improve target attainment of the area under the concentration curve in the first 24 h (AUC<sub>0-24</sub>).</p> Methods <p>This single-center, open-label, randomized controlled trial enrolled pediatric sepsis patients (3 months - 18 years) at King Chulalongkorn Memorial Hospital, Thailand. Patients were randomized 2:1 to receive a vancomycin loading dose or a standard dose. The primary outcome was achieving target AUC<sub>0-24</sub> (400–800 mg·h/L). An AUC0-24 &lt; 400 mg·h/L was defined as underdosing and &gt;800 mg·h/L as overdosing. Secondary outcomes included serious adverse events and factors influencing target attainment.</p> Results <p>Of 78 participants (loading dose <i>n</i> = 51; standard dose <i>n</i> = 27), overall target AUC₀₋₂₄ attainment did not differ significantly. However, the loading dose reduced AUC<sub>0-24</sub> underdosing and improved steady-state target attainment. No significant differences in 90-day mortality or acute kidney injury were observed. Estimated glomerular filtration rate and receiving the loading dose were associated with achieving a therapeutic AUC₀₋₂₄.</p> Conclusion <p>Although a loading dose did not increase overall target AUC₀₋₂₄ attainment, it reduced AUC<sub>0-24</sub> underdosing and improved steady-state target achievement without additional adverse events.</p> Impact <p><UnorderedList Mark="Bullet"> <ItemContent> <p>This randomized controlled trial showed that vancomycin loading doses in pediatric sepsis patients significantly reduced the proportion of patients with area under the concentration curve (AUC) in the first 24 h that were underdosing compared to the standard dose. The loading dose also improved target attainment of AUC over 24 h at steady-state levels, without increasing the risk of serious adverse events.</p> </ItemContent> <ItemContent> <p>This study highlights the importance of optimizing vancomycin dosing, particularly in patients with augmented renal clearance.</p> </ItemContent> <ItemContent> <p>These findings support incorporating a loading dose strategy into vancomycin therapy for pediatric sepsis patients, especially those with augmented renal clearance.</p> </ItemContent> </UnorderedList></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Vancomycin loading dose and AUC0-24 target attainment in pediatric sepsis: a single-center randomized controlled trial

  • 期刊论文

  • 发表日期：

    2026年5月22日

查看全文
  • Kritsaporn Sujjavorakul,
  • Stephen J. Kerr,
  • Noppadol Wacharachaisurapol,
  • Rujipat Samransamruajkit,
  • Thanyawee Puthanakit

摘要

Background

Achieving target vancomycin exposures is crucial for treating pediatric sepsis but is complicated by altered pharmacokinetics in critically ill children. This study investigated whether a loading dose improve target attainment of the area under the concentration curve in the first 24 h (AUC0-24).

Methods

This single-center, open-label, randomized controlled trial enrolled pediatric sepsis patients (3 months - 18 years) at King Chulalongkorn Memorial Hospital, Thailand. Patients were randomized 2:1 to receive a vancomycin loading dose or a standard dose. The primary outcome was achieving target AUC0-24 (400–800 mg·h/L). An AUC0-24 < 400 mg·h/L was defined as underdosing and >800 mg·h/L as overdosing. Secondary outcomes included serious adverse events and factors influencing target attainment.

Results

Of 78 participants (loading dose n = 51; standard dose n = 27), overall target AUC₀₋₂₄ attainment did not differ significantly. However, the loading dose reduced AUC0-24 underdosing and improved steady-state target attainment. No significant differences in 90-day mortality or acute kidney injury were observed. Estimated glomerular filtration rate and receiving the loading dose were associated with achieving a therapeutic AUC₀₋₂₄.

Conclusion

Although a loading dose did not increase overall target AUC₀₋₂₄ attainment, it reduced AUC0-24 underdosing and improved steady-state target achievement without additional adverse events.

Impact

This randomized controlled trial showed that vancomycin loading doses in pediatric sepsis patients significantly reduced the proportion of patients with area under the concentration curve (AUC) in the first 24 h that were underdosing compared to the standard dose. The loading dose also improved target attainment of AUC over 24 h at steady-state levels, without increasing the risk of serious adverse events.

This study highlights the importance of optimizing vancomycin dosing, particularly in patients with augmented renal clearance.

These findings support incorporating a loading dose strategy into vancomycin therapy for pediatric sepsis patients, especially those with augmented renal clearance.